Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure<4503.T>

Sun Apr 14, 2013 9:00pm EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

TOKYO,  April 14, 2013  /PRNewswire/ -- Astellas Pharma Inc.  ("Astellas"; 
Tokyo: 4503) today announced that  Songlin Xue, M.D., Ph.D. has been named head
of Global Pharmacovigilance (GPV). Dr. Xue will be located at Astellas'
Headquarters for the Americas in  Northbrook, Illinois, USA and will report to 
Sef Kurstjens, M.D., Ph.D., newly named Chief Medical Officer at Astellas. In 
April 2013, Astellas established the Chief Medical Officer position in order to
further integrate and enhance Astellas' delivery of global medical solutions.  

Astellas President and CEO  Yoshihiko Hatanaka  said, "I am pleased that Dr. Xue
will be joining us at Astellas as head of Global Pharmacovigilance. Dr. Xue's
knowledge and experience will help the company pursue its operational excellence
and further enhance our global PV and product compliance capabilities."

With Dr. Xue's appointment, Astellas has now completed the hiring of global
heads in the areas of PV, Medical Affairs, Regulatory Affairs, Clinical and
Research Quality Assurance, and Quality Assurance.  

During his more than twenty years in the pharmaceutical industry, Dr. Xue has
held increasingly senior roles with global responsibilities in drug safety and
pharmacoepidemiology.  Most recently, Dr. Xue held the position of Senior Vice
President, Head Global Pharmacovigilance at Takeda Pharmaceuticals, Inc. Prior
to joining Takeda, Dr. Xue held posts with global pharmaceutical companies such
as Novartis and Wyeth.   

Dr. Xue received his medical degree from Shanxi Medical College in Shanxi China.
 Subsequently, he received a Masters of Science (clinical epidemiology) degree
from Hunan University of Medical Science,  Hunan, China, and a Doctor of
Philosophy degree (Ph.D.) in epidemiology from the University of Minnesota.   

About Astellas Pharma Inc.
Astellas Pharma Inc., located in  Tokyo, Japan, is a pharmaceutical company
dedicated to improving the health of people around the world through the
provision of innovative and reliable pharmaceuticals. Astellas has approximately
17,000 employees worldwide. The organization is committed to becoming a global
category leader in Urology, Immunology (including Transplantation) and
Infectious Diseases, Oncology, Neuroscience and DM Complications and Kidney
Diseases. For more information on Astellas Pharma Inc., please visit the company
website at  

SOURCE  Astellas Pharma Inc.

Jenny Kite, Astellas, 224-205-5405

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.